Dossenheim, Germany

Oliver Müller

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Dossenheim, DE (2018 - 2022)
  • Heikendorf, DE (2023)

Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Oliver Müller: Innovator in Cardiovascular Therapeutics

Introduction

Oliver Müller is a prominent inventor based in Dossenheim, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic approaches for cardiovascular diseases. With a total of 3 patents, his work focuses on innovative solutions that address critical health issues.

Latest Patents

Müller's latest patents include groundbreaking inventions such as NFAT binding polynucleotides. This invention relates to a polynucleotide that comprises a Nuclear factor of activated T-cells (NFAT) binding site sequence and a reverse complement of said NFAT binding site sequence, separated by a spacer sequence. This polynucleotide is designed for use in treating and/or preventing diseases, as well as for the development of viral particles and related compositions. Another notable patent is centered around ABHD5 and partial HDAC4 fragments and variants, which serve as a therapeutic approach for treating cardiovascular diseases. This invention focuses on Abhydrolase containing domain 5 (ABHD5) and N-terminal fragments of HDAC4 (HDAC4-NT) for the treatment and prevention of heart failure. It also provides vectors for cardiomyocyte-specific expression of these peptides.

Career Highlights

Throughout his career, Oliver Müller has worked with esteemed institutions such as Ruprecht-Karls-University Heidelberg and Universität Heidelberg. His research has significantly advanced the understanding of cardiovascular health and disease.

Collaborations

Müller has collaborated with notable professionals in his field, including Hugo Katus and Johannes Backs. These partnerships have further enriched his research and contributed to the development of innovative therapeutic solutions.

Conclusion

Oliver Müller stands out as a key figure in the realm of cardiovascular therapeutics, with a focus on innovative inventions that have the potential to transform treatment approaches. His contributions continue to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…